6.3 Local Anesthesia Complications, Toxicity & Nitrous Oxide Sedation

Local Anesthesia Complications, Toxicity & Nitrous Oxide Sedation

Systemic Local Anesthetics Toxicity

Local Anesthetic Systemic Toxicity (LAST)

Local Anesthetic Systemic Toxicity (LAST) is a life-threatening adverse event resulting from high blood concentrations of local anesthetic. High systemic concentrations occur due to accidental intravascular injection, excessive total drug dosage, rapid tissue absorption, or impaired hepatic biotransformation.

Local anesthetics readily cross the blood-brain barrier. The central nervous system (CNS) is significantly more sensitive to local anesthetic toxicity than the cardiovascular system (CVS).

LAST Progression Path
├── CNS Excitation (Lightheaded, Tinnitus, Metallic Taste, Tremors)
├── CNS Depression (Seizures, Unconsciousness, Respiratory Arrest)
└── CVS Collapse (Bradycardia, Hypotension, Arrhythmias, Asystole)

• Initial CNS Excitatory Phase: At low-to-moderate toxic blood levels, local anesthetics selectively depress inhibitory cortical pathways. Inhibitory neurons are suppressed first, unmasking excitatory pathways. Clinical signs include:
  • Lightheadedness, dizziness, anxiety, restlessness, talkativeness
  • Auditory disturbances (tinnitus / ringing in ears) and visual disturbances
  • Circumoral numbness, numbness of tongue and lips, metallic taste
  • Muscle twitching, facial tremors, slurred speech
• Advanced CNS Depressatory Phase: As blood levels rise further, both inhibitory and excitatory pathways are depressed, producing generalized CNS depression:
  • Generalized tonic-clonic seizures
  • Loss of consciousness, coma
  • Respiratory depression and respiratory arrest
• Cardiovascular System (CVS) Toxicity: Local anesthetics decrease electrical excitability, conduction velocity, and contractile force of the myocardium. High blood levels cause severe peripheral vasodilation, profound hypotension, bradycardia, ventricular arrhythmias, and cardiac arrest. Bupivacaine is the most cardiotoxic local anesthetic due to its high lipid solubility and slow dissociation from cardiac sodium channels.

Emergency Management of LAST

1. Stop local anesthetic administration immediately.
2. Request emergency medical assistance (Call 911 / EMS).
3. Position patient supine; maintain open airway and administer 100% high-flow Oxygen.
4. Protect patient from self-injury during tonic-clonic seizure activity.
5. Administer 20% Lipid Emulsion Therapy (Intralipid) intravenously (first-line antidote that traps lipophilic local anesthetic molecules in intravascular space, drawing them away from brain and heart tissue).

Vasoconstrictor Toxicity vs LAST

Vasoconstrictor (epinephrine) toxicity is caused by accidental intravascular injection or excessive vasoconstrictor dosage. It manifests as a sympathomimetic reaction:

• Severe headache, intense anxiety, trembling, palpitations, tachycardia, cardiac arrhythmias, and marked hypertension.
• Unlike LAST, epinephrine toxicity does not produce seizures or CNS depression, and symptoms subside rapidly as epinephrine is metabolized by catechol-O-methyltransferase (COMT) and monoamine oxidase (MAO).

Local Complications of Local Anesthesia

Local Complications
├── Hematoma: Vessel puncture (PSA highest risk) -> Pressure 2 min, Ice 24h, Heat after 24h
├── Trismus: Medial pterygoid spasm -> Heat therapy, warm saline, muscle relaxants
├── Paresthesia: Direct needle trauma / 4% solutions -> Reassurance & monitoring
├── Facial Paralysis: Parotid injection (CN VII) -> Eye patch, artificial tears
└── Methemoglobinemia: Prilocaine/Benzocaine metabolite -> IV Methylene Blue (1-2 mg/kg)

Hematoma

A hematoma is an effusion of blood into extravascular tissue spaces caused by accidental puncture of a blood vessel during injection. The PSA block carries the highest risk of hematoma (pterygoid plexus of veins), followed by the IA block.

• Management: Apply immediate direct firm pressure over the bleeding site for at least 2 minutes. Apply ice packs intermittently for the first 24 hours to induce vasoconstriction and limit swelling. After 24 hours, apply warm moist heat to promote vasodilation and resorption of extravasated blood. Analgesics (acetaminophen) may be prescribed; avoid NSAIDs if active bleeding is suspected.

Trismus

Trismus is defined as motor disturbance of the trigeminal nerve causing spasm of the masticatory muscles, resulting in restricted mouth opening. It occurs most frequently after an IA nerve block due to direct needle trauma or hematoma formation within the medial pterygoid muscle.

• Management: Warm moist heat therapy for 20 minutes every hour, warm saline rinses, analgesics (NSAIDs), soft diet, and gentle jaw-opening exercise. If severe, muscle relaxants (cyclobenzaprine) may be prescribed.

Paresthesia

Paresthesia is persistent anesthesia or altered sensation (numbness, tingling, dysesthesia) lasting beyond the expected duration of anesthesia. Causes include direct needle trauma to the nerve trunk, neurotoxicity from high-concentration anesthetics (4% Articaine and 4% Prilocaine exhibit higher statistical incidence of paresthesia post-IA block), or hemorrhage into the nerve sheath.

• Management: Reassure patient, record precise areas of altered sensation, conduct sensory testing (sharp/dull discrimination), and arrange follow-up. Most paresthesias resolve spontaneously within 8 to 8 weeks.

Methemoglobinemia

Methemoglobinemia is a condition in which the ferrous iron ($Fe^{2+}$) in hemoglobin is oxidized to ferric iron ($Fe^{3+}$), forming methemoglobin. Methemoglobin cannot bind or transport oxygen and shifts the oxygen-hemoglobin dissociation curve to the left, preventing oxygen release to peripheral tissues.

• Etiology: Induced primarily by Prilocaine (via metabolite ortho-toluidine), topical Benzocaine spray/gel, or high doses of Articaine.
• Clinical Signs: Slate-blue cyanosis of lips, tongue, and nail beds that does not respond to 100% oxygen; lethargy; dyspnea; and characteristically chocolate-brown colored blood.
• Treatment: Intravenous administration of Methylene Blue (1 to 2 mg/kg of 1% solution over 5 minutes). Methylene blue acts as an electron donor to reduce methemoglobin back to functional hemoglobin.

Nitrous Oxide / Oxygen ($N_2O/O_2$) Inhalation Sedation

Physicochemical & Pharmacological Properties

Nitrous oxide ($N_2O$) is an inorganic, colorless, non-irritating, sweet-smelling gas used as a conscious anxiolytic and analgesic agent in dental hygiene practice.

• Blood-Gas Partition Coefficient (Solubility): $N_2O$ has a very low blood-gas solubility coefficient of 0.47. Because it is relatively insoluble in blood, $N_2O$ rapidly saturates blood plasma, resulting in rapid onset of action (3-5 minutes) and rapid recovery once discontinued.
• Minimum Alveolar Concentration (MAC): MAC is the concentration of gas that prevents movement in 50% of subjects exposed to a surgical stimulus. The MAC of $N_2O$ is 104%. Because MAC exceeds 100%, $N_2O$ cannot produce surgical stage III general anesthesia under normal barometric pressure without producing hypoxia.
• Analgesic Properties: A mixture of 20% $N_2O$ and 80% $O_2$ produces an analgesic effect equivalent to 15 mg of subcutaneous morphine.

Administration and Titration Protocol

1. Establish Baseline Flow: Place mask and establish total gas flow rate (typically 6-8 L/min for adults, 4-5 L/min for children) administering 100% $O_2$ for 2-3 minutes.
2. Incremental Titration: Introduce $N_2O$ at 10% to 20% concentration. Increase $N_2O$ in 5% to 10% increments every 60 to 90 seconds while observing patient responses until ideal sedation level is achieved (typically 30% to 50% $N_2O$).
3. Ideal Sedation Signs: Patient remains fully conscious, relaxed, responsive to verbal commands; eyes appear glossy; patient reports tingling sensation in fingers/toes or feeling of warmth/lightness.
4. Post-Procedure Oxygenation: At completion of procedure, turn off $N_2O$ flow completely and administer 100% Oxygen for a MINIMUM of 5 minutes.

Diffusion Hypoxia

If $N_2O$ administration is abruptly terminated and the patient breathes room air directly, $N_2O$ diffuses out of blood into the pulmonary alveoli far faster than nitrogen can absorb into blood. This massive influx of $N_2O$ dilutes the concentration of alveolar oxygen, leading to Diffusion Hypoxia. Symptoms include headache, dizziness, nausea, and lethargy. Administering 100% $O_2$ for 5 minutes post-procedure flushes $N_2O$ safely from lungs and prevents diffusion hypoxia.

Contraindications for $N_2O/O_2$ Sedation

Occupational Safety and Scavenging Systems

Chronic occupational exposure to waste nitrous oxide gas in dental operatories poses health hazards to dental personnel. $N_2O$ oxidizes and inactivates Vitamin $B_{12}$ by inhibiting the enzyme methionine synthase. Chronic exposure causes megaloblastic bone marrow changes, peripheral neuropathy, and increased risk of spontaneous abortion.

• Scavenging Controls: Operatories must utilize a double-mask scavenging nasal hood attached to a central vacuum system calibrated to a suction flow rate of 45 Liters per minute (L/min).
• NIOSH Exposure Limit: The National Institute for Occupational Safety and Health (NIOSH) sets a Recommended Exposure Limit (REL) of 25 ppm of $N_2O$ in dental operatories during administration.